Dean Schorno

23andMe has appointed Dean Schorno its CFO and head of operations. He will oversee 23andMe's global financial and clinical laboratory operations. Schorno was most recently CFO of Adaptive Biotechnologies. Before that he held executive leadership positions at Genomic Health. 


Arthur Beaudet, Laurel Estabrooks, Laura Furmanski, Anthony Romaine Gregg 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.